Copyright
©The Author(s) 2017.
World J Gastroenterol. Jul 7, 2017; 23(25): 4569-4578
Published online Jul 7, 2017. doi: 10.3748/wjg.v23.i25.4569
Published online Jul 7, 2017. doi: 10.3748/wjg.v23.i25.4569
Figure 4 Effect of SMARCE1 on hepatitis B virus replication and expression (n = 3).
A: HepG2.2.15 cells were transfected with pcDNA-control, pcDNA-SMARCE1, si-control, or si-SMARCE1 for 24 h; B and E: Western blotting was performed to detect the level of SMARCE1 after pcDNA-SMARCE1 or si-SMARCE1 transfection; C and D: qPCR and Southern blotting analysis showed that SMARCE1 overexpression significantly reduced the HBV DNA replication and SMARCE1 knockdown significantly increased the HBV DNA replication; F and G: ELISA assay showed that SMARCE1 overexpression significantly decreased the levels of HBsAg and HBeAg; H and I: Endogenous SMARCE1 inhibition by si-SMARCE1 significantly promoted the levels of HBsAg and HBeAg. aP < 0.05 vs controls. Data represent the mean ± SD.
- Citation: Wu HJ, Zhuo Y, Zhou YC, Wang XW, Wang YP, Si CY, Wang XH. miR-29a promotes hepatitis B virus replication and expression by targeting SMARCE1 in hepatoma carcinoma. World J Gastroenterol 2017; 23(25): 4569-4578
- URL: https://www.wjgnet.com/1007-9327/full/v23/i25/4569.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i25.4569